8-K - Xenetic Biosciences, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Xenetic Biosciences, Inc. filed an 8-K on March 13, 2026, disclosing financial results for the period via Exhibit 99.1 press release under Item 2.02. The filing references historical EPS performance positively beating analyst consensus estimates.

Key Takeaways

1Form 8-K filed 2026-03-13

2Item 2.02 Results of Operations

3Exhibit 99.1 Press Release dated 2026-03-13

4Historical EPS: 2026-03-12 $-0.22 vs est $-0.52 (+57.7%)

52025-11-12 EPS $-0.33 vs est $-0.49 (+32.7%)

62025-08-12 EPS $-0.45 vs est $-0.64 (+29.7%)

Current Report Details

Event Type

Financial Results

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

by reference. The information in this Item 2.02, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securitie

Financial Results

9.01

. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated March 13, 2026 pertaining to the financial results of the Com

Exhibits Only

Source Document

Exhibits (2)

8-K

CURRENT REPORT

99.1

PRESS RELEASE